RA
CVET

Royce & Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History

Royce & Associates’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-267,100
Closed -$4.49M – 1003
2022
Q1 		$4.49M Buy
+267,100
New +$4.67M 0.04% 573
2019
Q2 		– Sell
-130,000
Closed -$4.14M – 1207
2019
Q1 		$4.14M Buy
+130,000
New +$4.61M 0.04% 548

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates's CVET Position: Q2 2022 in Review

Royce & Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 267,100 shares — an estimated $4.49M sold.

Royce & Associates first reported a position in CVET in Q1 2019 and held it in 2 quarters. The position peaked at $4.49M in Q1 2022. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • Royce & Associates reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Royce & Associates sold 267,100 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $4.49M.
  • Royce & Associates first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Royce & Associates's Covetrus, Inc. Common Stock position peaked at $4.49M in Q1 2022.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.